Literature DB >> 1687607

Role of T cells in resistance to Theiler's virus infection.

M Rodriguez1, M D Lindsley, M L Pierce.   

Abstract

Intracerebral infection of C57BL/10SNJ mice with Theiler's virus results in acute encephalitis with subsequent virus clearance and absence of spinal cord demyelination. In contrast, infection of SJL/J mice results in acute encephalitis, virus persistence, and immune-mediated demyelination. These experiments examined the role of T-cell subsets in the in vivo immune response to Theiler's virus in resistant C57BL/10SNJ mice. Depletion of T-cell subsets with monoclonal antibodies (mAbs) directed at CD3 (pan-T-cell marker), CD4+ (class II-restricted) or CD8+ (class I-restricted) T cells resulted in increased frequency of paralysis and death as a result of acute encephalitis. Neuropathologic studies 10 days after infection demonstrated prominent necrosis, primarily in the pyramidal layer of hippocampus and in the thalamus of mice depleted of T-cell subsets. In immunosuppressed and infected C57BL/10SNJ mice, analysis of spinal cord sections 35 days after infection demonstrated small demyelinated lesions relatively devoid of inflammatory cells even though virus antigen could be detected by immunocytochemistry. Both CD4+ and CD8+ T cells are important in the resistance to infection with Theiler's virus in C57BL/10SNJ mice. However, subsequent spinal cord demyelination, to the extent observed in susceptible mice, depends on the presence of virus antigen persistence and a competent cellular immune response.

Entities:  

Mesh:

Year:  1991        PMID: 1687607      PMCID: PMC7127457          DOI: 10.1016/0882-4010(91)90031-5

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  35 in total

1.  Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.

Authors:  R Hirsch; R E Gress; D H Pluznik; M Eckhaus; J A Bluestone
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

2.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection.

Authors:  H L Lipton; J Kratochvil; P Sethi; M C Dal Canto
Journal:  Neurology       Date:  1984-08       Impact factor: 9.910

4.  Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination.

Authors:  M Rodriguez; J Quddus
Journal:  J Neuroimmunol       Date:  1986-12       Impact factor: 3.478

5.  Immune-mediated injury of virus-infected oligodendrocytes A model of multiple sclerosis.

Authors:  M Rodriguez; L R Pease; C S David
Journal:  Immunol Today       Date:  1986-12

6.  Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.

Authors:  R S Fujinami; A Rosenthal; P W Lampert; A Zurbriggen; M Yamada
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  The effect of short-term and chronic immunosuppression on Theiler's virus demyelination.

Authors:  R P Roos; S Firestone; R Wollmann; D Variakojis; B G Arnason
Journal:  J Neuroimmunol       Date:  1982-06       Impact factor: 3.478

8.  Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.

Authors:  M Chamorro; C Aubert; M Brahic
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

9.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

10.  SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE.

Authors:  M Theiler
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

View more
  11 in total

1.  In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence.

Authors:  E L Larsson-Sciard; S Dethlefs; M Brahic
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

2.  Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus Infection.

Authors:  Zachariah P Tritz; Robin C Orozco; Courtney S Malo; Katayoun Ayasoufi; Cori E Fain; Roman H Khadka; Emma N Goddery; Lila T Yokanovich; Megan L Settell; Michael J Hansen; Fang Jin; Kevin D Pavelko; Larry R Pease; Aaron J Johnson
Journal:  J Immunol       Date:  2020-07-31       Impact factor: 5.422

3.  Gamma interferon is critical for resistance to Theiler's virus-induced demyelination.

Authors:  M Rodriguez; K Pavelko; R L Coffman
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Interleukin-6 protects anterior horn neurons from lethal virus-induced injury.

Authors:  Kevin D Pavelko; Charles L Howe; Kristen M Drescher; Jeff D Gamez; Aaron J Johnson; Tao Wei; Richard M Ransohoff; Moses Rodriguez
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

5.  Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice.

Authors:  M K Njenga; K D Pavelko; J Baisch; X Lin; C David; J Leibowitz; M Rodriguez
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

7.  Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.

Authors:  Moses Rodriguez; Laurie J Zoecklein; Charles L Howe; Kevin D Pavelko; Jeff D Gamez; Shunya Nakane; Louisa M Papke
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection.

Authors:  I Subak-Sharpe; H Dyson; J Fazakerley
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 9.  Immunology of Theiler's murine encephalomyelitis virus infection.

Authors:  E L Oleszak; J Kuzmak; R A Good; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 10.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.